SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-042697
Filing Date
2020-02-20
Accepted
2020-02-20 07:55:03
Documents
4
Period of Report
2020-02-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d882631d8k.htm 8-K 27064
2 EX-10.1 d882631dex101.htm EX-10.1 64357
3 EX-99.1 d882631dex991.htm EX-99.1 12364
4 GRAPHIC g882631g0218235252682.jpg GRAPHIC 3448
  Complete submission text file 0001193125-20-042697.txt   110065
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 20632572
SIC: 2834 Pharmaceutical Preparations